John Holden

John HoldenJohn spent most of his career in policy roles at the Department of Health and is now Director of Policy, Partnerships and Innovation for NHS England. He helped to set the organisation up, and is now responsible for coordinating NHS England’s policy on a range of issues. He also manages NHS England’s formal accountability to Ministers and Parliament.

 

The new Congenital Heart Disease review: 43rd update – John Holden

Welcome to my final blog for the congenital heart disease review; a blog in two parts. In the second part of this blog Will Huxter, the senior manager now responsible for the work, will introduce himself and explain how NHS England is taking things forward. In Blog 42 I explained that a report on the […]

Read more

The new Congenital Heart Disease review: 42nd update – John Holden

In July 2013 the Board of NHS England accepted responsibility for a new review of CHD services, and outlined the approach we would take.  Almost exactly two years later, on 23 July 2015, we are bringing a report back to our Board, which describes the conclusions of the review, based on the six objectives which […]

Read more

The new Congenital Heart Disease review: 41st update – John Holden

Your feedback Welcome back!  One or two of you said you missed the blog during the restricted election period so – by “massive public demand” – it’s back.  We have been continuing the work of the review, finalising the proposed standards, discussing with providers how the standards could be met, and working ever more closely […]

Read more

The new Congenital Heart Disease review: 40th update – John Holden

Your feedback We’ve been asked whether NHS England can “look under the bonnet” of the independent report on our recent consultation – for example, can we see the detail of individual responses?  The answer is yes, we can. Our review team has already read every single response that came in, and if we need to […]

Read more

The new Congenital Heart Disease review: 39th update – John Holden

I am pleased to announce the publication of the independent report ‘Consultation on draft standards and service specifications for the congenital heart disease service‘ which has been produced by Dialogue by Design. The report has been published on Dialogue by Design’s website. This is an important step in our work to develop standards to improve […]

Read more

The new Congenital Heart Disease review: 38th update – John Holden

Nature abhors a vacuum, so I try to keep blogging regularly, in case you think we have gone away or eased up on the work of the review.   We haven’t. But there really is not a lot to report this week in terms of meetings or public notices…… Your feedback We have resumed the pattern […]

Read more

The new Congenital Heart Disease review: 37th update – John Holden

Welcome to the first blog for 2015. It’s been a month since the last one – I thought I should allow you to enjoy the festive season in peace! However, the work on the review has not stopped and we continue where we left off. Your feedback From the conversations I’ve had recently I know […]

Read more

The new Congenital Heart Disease review: 36th update – John Holden

Your feedback Our consultation on draft standards and service specifications closed on Monday 8 December, and we’ve received more than 500 responses, which are currently being analysed. We will say more about the next steps, and likely timetable, in the new year.  Thank you to everyone who has responded. Patients, families and their representatives The next […]

Read more

The new Congenital Heart Disease review: 35th update – John Holden

Your feedback We continue to receive your feedback to the consultation and welcome your comments.   Although the “road show” has finished, the consultation period continues until 5pm on 8 December and we are keen to encourage as many people as possible to share their views with us; further details are available here.  More information about the […]

Read more

The new Congenital Heart Disease review: 34th update – John Holden

Your feedback We’ve had a query about the data we use to understand activity levels for CHD, and whether we include private patients, or those from the Republic of Ireland, etc. It seems there is some misunderstanding about this, so to help explain our approach we’ve produced a short note which you can read here. […]

Read more